Matritech financed the approval of their bladder cancer test but for whatever reason, the test was not licensed. Their share holders certainly got the shaft in that deal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.